Kathleen Jaeger of America's Generic Pharmaceutical Association adds that branded firms try to extend their lucrative monopolies by filing less rigorous secondary patents designed “to block generics”.

美国通用药物协会的KathleenJaeger补充说很多品牌药公司制作大量的文件申请专利分案“以阻碍仿制药”。